AG1 vs Care/of
Side-by-side comparison of AI visibility scores, market position, and capabilities
Single-SKU greens supplement brand projecting $600M revenue in 2025 at $1.2B valuation; built almost entirely on DTC subscriptions with no retail distribution; endorsed by Andrew Huberman and powered by word-of-mouth among health-conscious consumers.
About
AG1 (formerly Athletic Greens) is a New Zealand-founded, US-focused nutritional supplement company that manufactures a single flagship product: a daily all-in-one greens powder. Founded in 2010 and now headquartered in Las Vegas, the company bootstrapped to approximately $160 million in revenue before raising $115 million in a growth round in January 2022 at a $1.2 billion valuation, led by Alpha Wave Global.\n\nAG1 projects revenue of approximately $600 million in 2025, driven almost entirely by direct-to-consumer subscriptions sold online. The company has no retail distribution and no SKU diversification — an unusual strategy that has proven powerful for brand clarity and margin preservation. AG1 products are endorsed by high-profile athletes and health podcasters including Andrew Huberman, fueling viral word-of-mouth and podcast advertising at scale.\n\nIn 2025 the company began expanding into complementary product lines while retaining its minimalist brand identity. Its subscription model creates strong LTV economics, and the company has been reportedly cash-flow positive since well before its funding round. AG1 is often cited as a benchmark for DTC supplement brand building.
Personalized vitamin subscription brand acquired by Bayer for $225M in 2020; continues as digital-native supplement label under Bayer Consumer Health.
About
Care/of is a New York-based personalized vitamin and supplement brand founded in 2016 by Craig Elbert and Akash Shah. The company popularized algorithm-driven supplement personalization, asking consumers a series of lifestyle and health questions to recommend a custom daily vitamin pack delivered by subscription. Care/of was acquired by Bayer in November 2020 at a $225 million valuation, giving Bayer a majority ownership stake in the direct-to-consumer brand.\n\nUnder Bayer's Consumer Health division, Care/of has continued to operate with its original DTC model and brand identity while leveraging Bayer's supply chain, clinical validation resources, and marketing infrastructure. The brand extended its product line to include protein powders, collagen supplements, and wellness shots, maintaining its personalization-first positioning in a crowded supplement market.\n\nCare/of targets millennial consumers who value personalized wellness plans and want evidence-cited ingredient explanations. The brand's website provides research citations for every recommended ingredient, a transparency approach that built early credibility and loyalty. As part of Bayer, Care/of benefits from credentialing by association with a global pharmaceutical brand while retaining its digital-native identity.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.